Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.34 |
| ▸ | CDC25B | P30305 | 7/20 | 0.33 |
| ▸ | CDC25A | P30304 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.33 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.33 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4169540 | 0.92 | LGALS3 (0.40) | GRM5LGALS3PTPN1PTPN2CDC25B | |
| SCHEMBL4178365 | 0.88 | NT5E (0.41) | GRM5LGALS3PTPN1PTPN2CDC25B | |
| SCHEMBL6553216 | 0.85 | GRM5 (0.41) | GRM5LGALS3PTPN1PTPN2BCHE | |
| SCHEMBL6553208 | 0.82 | LGALS3 (0.46) | GRM5LGALS3BCHE | |
| SCHEMBL6553329 | 0.82 | CYP3A4 (0.41) | LGALS3NT5E | |
| SCHEMBL6553337 | 0.82 | CYP3A4 (0.41) | LGALS3NT5E | |
| SCHEMBL4169535 | 0.82 | GRM5 (0.36) | GRM5LGALS3PTPN1PTPN2CDC25B | |
| SCHEMBL26102300 | 0.81 | SSTR1 (0.42) | PTPN1PTPN2CDC25BSSTR1SSTR2 | |
| SCHEMBL3756883 | 0.80 | NT5E (0.43) | PTPN1PTPN2CDC25BNT5EPTPN6 | |
| SCHEMBL27002581 | 0.80 | NT5E (0.43) | PTPN1PTPN2CDC25BNT5EPTPN6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | GLYCOFORM LIMITED (GB) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | TST, TREH, FUT6 | GRM5 4649/4885LGALS3 680/4885PTPN1 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.